Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron sucrose in anemia of cancer patients on chemotherapy and EPO
NCT00236951Phase 3Completed
- Sponsor
- American Regent, Inc.
- Start
- Feb 2003
- Primary completion
- Oct 2005
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of iron sucrose in anemia (4 arms), sponsored by American Regent, Inc. Primary endpoint: Change From Baseline to the Maximum Hemoglobin Level During Stage 2 at 21 weeks. Started Feb 2003; status: completed.
02
Drugs
iron sucrose
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00236951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00236951.